Research & Development

Research & Development

Sustaining Dar Al Dawa’s growth over the long term is a function of our commitment to Research and Development and the results that this investment delivers.  Our Pharmaceutical Development Unit focuses on developing new forms to render high-quality affordable medicines accessible to patients.

We have in depth knowledge and hands on experience in the formulation and process development of various dosage forms including tablets (IR and MR), capsules, liquids, dry suspensions, suppositories, creams, ointments, gels, parenterals, ophthalmic and nasal preparations. Our labs are equipped with modern instruments and equipment that enable us to develop and optimize various formulation designs and concepts.

The Analytical Research unit has the knowledge and expertise in analytical method development, validation, physiochemical characterization and stability studies.

Since we began our research and development activities, we have filed Investigational New Drug applications and progressed multiple proprietary compounds into clinical and commercial development. In March 2013, we were ranked the first company by Jordan Drugstore Association in terms of new drug applications and hence we have a rich pipeline that will drive our growth.

In an industry that is technology driven, Dar Al Dawa’s  Research &Development  is working on new technologies and processes that complement existing product lines and achieve product life cycle management

Corporate Governance

Dar Al Dawa has a firmly established policy of conducting our affairs in compliance with the letter and spirit of the law and adhering to the principles of business ethics. Our policies are designed to ensure that the company conducts its business for the benefit of all its stakeholders – our customers, employees, shareholders, suppliers, and host communities. The framework will be certified this year. Our Business Conduct Guidelines reaffirm our commitment to integrity as the cornerstone of our business practice. They are intended to remind us of our legal and ethical obligations. All employees, directors, contract workers, and others who act on behalf of Dar Al Dawa are expected to abide by and uphold these guidelines.

We have entered into a different collaboration and licencing agreements with different global pharmaceutical leaders.

These include:

  • Novartis

  • Sanofi Aventis

  • Mylan

  • Meas

  • Polpharma

  • Orion

  • Pfizer

  • Pharmathen

  • Farmaticker

  • ADM Farm

  • Chanelle Medical